Effect of Lysine and Phosphorus Fortification on Glycemic Index and Postprandial Glycemia in Double Fortified Bread (LP-DFB-GI-PG)
Hyperglycemia, Glucose Metabolism Disorders, Metabolic Disease
About this trial
This is an interventional prevention trial for Hyperglycemia focused on measuring Glycemic Index, Postprandial Glycemia, Lysine, Phosphorus, White bread, Glycemic Control
Eligibility Criteria
Inclusion Criteria: Subjects are appropriate if they are in the age range between 18 and 35 years. Subjects should be within normal range of BMI 18.5 to 24.5 kg per meter square. Efforts will be made to age and gender match subjects Exclusion Criteria: Subjects with diabetes, cardiovascular, cerebrovascular, pulmonary, hepatic, renal, endocrinological (PTH), or any significant medical disease will be excluded. Pregnant and lactating women. Subjects on regular use of any medication and supplements. Subjects that have any type of food allergy.
Sites / Locations
- University of Veterinary and Animal SciencesRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
Experimental
Control Group - Standard White Bread
Lysine Group - Lysine-Fortified Bread
Phosphorus Group - Phosphorus-Fortified Bread
Lysine and Phosphorus Group - Double Fortified Bread
This arm serves as the control group in the clinical trial, providing a baseline comparison for the intervention arms. Participants in this arm consume standard white bread
This arm investigates the effect of lysine-fortified bread on glycemic response. Participants in this arm consume bread fortified with lysine, an essential amino acid.
This arm explores the impact of phosphorus-fortified bread on glycemic response. Participants in this arm consume bread fortified with phosphorus, an essential mineral.
This arm examines the combined effect of lysine and phosphorus in double fortified bread on glycemic response. Participants in this arm consume bread fortified with both lysine and phosphorus.